Sionna Therapeutics earnings were -$70.7M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. The latest SION earnings report on Sep 30, 2025 announced Q3 2025 earnings of -$20.3M, up 12.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, SION reported annual earnings of -$61.7M, with 30.5% growth.
Sionna Therapeutics Earnings Reports & History FAQ
What were Sionna Therapeutics's earnings last quarter?
On SION's earnings call on Invalid Date, Sionna Therapeutics (NASDAQ: SION) reported Q3 2025 earnings per share (EPS) of -$0.46, up 91.89% year over year. Total SION earnings for the quarter were -$20.28 million. In the same quarter last year, Sionna Therapeutics's earnings per share (EPS) was -$5.67.
Is Sionna Therapeutics profitable or losing money?
As of the last Sionna Therapeutics earnings report, Sionna Therapeutics is currently losing money. Sionna Therapeutics's net profit (also called net income) for the twelve months ending Sep 30, 2025 was -$70.68 million, a 22.45% increase year over year.
What was SION's earnings growth in the past year?
As of Sionna Therapeutics's earnings date in Invalid Date, Sionna Therapeutics's earnings has grown year over year. SION earnings in the past year totalled -$70.68 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.